Use of complement binding assays to assess the efficacy of antibody mediated rejection therapy and prediction of graft survival in kidney transplantation

Daniel S. Ramón(University of Michigan), Milagros Samaniego(Henry Ford Health System), Yihung Huang(University of Michigan), Randall S. Sung(University of Michigan), Lili Zhao(University of Michigan), Jeong Mi Park(The Catholic University of Korea Seoul St. Mary's Hospital), TrisAnn Rendulic(University of Michigan)
Human Immunology
November 25, 2016
10.1016/j.humimm.2016.11.009
Cited by 23

Related Papers

KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update
|American Journal of Kidney Diseases|2015|1.3k
Effect of Regional vs General Anesthesia on Incidence of Postoperative Delirium in Older Patients Undergoing Hip Fracture Surgery
|JAMA|2021|393
ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma
|Science Translational Medicine|2016|307
Plasmapheresis, CMV Hyperimmune Globulin, and Anti-CD20 Allow ABO-Incompatible Renal Transplantation Without Splenectomy
|American Journal of Transplantation|2004|283
Adverse Outcomes of Tacrolimus Withdrawal in Immune–Quiescent Kidney Transplant Recipients
|Journal of the American Society of Nephrology|2015|193